These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25877323)

  • 41. Lung cancer management concerns in New Zealand.
    Garrett J
    N Z Med J; 2004 Jun; 117(1196):U929. PubMed ID: 15280933
    [No Abstract]   [Full Text] [Related]  

  • 42. An overview of lung cancer symptoms, pathophysiology, and treatment.
    Yoder LH
    Medsurg Nurs; 2006 Aug; 15(4):231-4. PubMed ID: 16999185
    [No Abstract]   [Full Text] [Related]  

  • 43. Lung cancer: needs assessment, treatment and therapies.
    Evans M
    Br J Nurs; 2013 Sep 12-25; 22(17):S15-6, S18, S20-2. PubMed ID: 24067269
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Managing patients with lung cancer. Guidelines must help bring us in line with European standards.
    O'Brien ME; Cullen M
    BMJ; 2000 Jun; 320(7249):1604-5. PubMed ID: 10896440
    [No Abstract]   [Full Text] [Related]  

  • 45. Chinese consensus on early diagnosis of primary lung cancer (2014 version).
    Hu J; Qian GS; Bai CX;
    Cancer; 2015 Sep; 121 Suppl 17():3157-64. PubMed ID: 26331822
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Managing patients with lung cancer. New guidelines should improve standards of care.
    Simmonds P
    BMJ; 1999 Aug; 319(7209):527-8. PubMed ID: 10463876
    [No Abstract]   [Full Text] [Related]  

  • 47. [Expert consensus on standardization of the management of primary liver cancer].
    Ye SL
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):403-10. PubMed ID: 19645134
    [No Abstract]   [Full Text] [Related]  

  • 48. [Therapeutic standards and perspectives for stage IV non-small cell lung cancer].
    Reck M; Rosell R; Tiemann M
    Onkologie; 2012; 35 Suppl 3():10-3. PubMed ID: 22678019
    [No Abstract]   [Full Text] [Related]  

  • 49. Oncologists push beyond new lung cancer genomic testing guidelines.
    Garber K
    J Natl Cancer Inst; 2015 Feb; 107(2):. PubMed ID: 25677038
    [No Abstract]   [Full Text] [Related]  

  • 50. SEOM-SERAM-SEMNIM guidelines on the use of functional and molecular imaging techniques in advanced non-small-cell lung cancer.
    Fernández-Pérez G; Sánchez-Escribano R; García-Vicente AM; Luna-Alcalá A; Ceballos-Viro J; Delgado-Bolton RC; Vilanova-Busquets JC; Sánchez-Rovira P; Fierro-Alanis MP; García-Figueiras R; Alés-Martínez JE
    Clin Transl Oncol; 2018 Jul; 20(7):837-852. PubMed ID: 29256154
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Clinical practice guideline for lung cancer].
    Hayakawa K; Tsuboi M
    Gan To Kagaku Ryoho; 2010 Apr; 37(4):609-12. PubMed ID: 20414015
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [New perspectives in the management of non-small-cell lung carcinoma (NSCLC)].
    Brockmöller J; Junker K; Multhoff G
    Onkologie; 2006 Sep; 29 Suppl 2():25-8. PubMed ID: 16974125
    [No Abstract]   [Full Text] [Related]  

  • 53. Updated ACCP Guidelines for the diagnosis and management of lung cancer: what are the important changes in recommendations?
    Alberts WM
    Pol Arch Med Wewn; 2008; 118(1-2):4-5. PubMed ID: 18405165
    [No Abstract]   [Full Text] [Related]  

  • 54. Is VAMLA/TEMLA the new standard of preresection staging of non-small cell lung cancer?
    Yendamuri S; Demmy TL
    J Thorac Cardiovasc Surg; 2012 Sep; 144(3):S14-7. PubMed ID: 22503199
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Standards, Options and Recommendations for the management of non-small cell lung carcinoma patients].
    Depierre A; Lagrange JL; Theobald S; Astoul P; Baldeyrou P; Bardet E; Bazelly B; Bréchot JM; Breton JL; Douillard JY; Grivaux M; Jacoulet P; Khalil A; Lemarié E; Martinet Y; Massard G; Milleron B; Molina T; Moro-Sibilot D; Paesmans M; Pujol JL; Quoix E; Ranfaing E; Rivière A; Sancho-Garnier H; Souquet JP; Spaeth D; Stoebner-Delbarre A; Thiberville L; Touboul E; Vaylet F; Vergnon JM; Westeel V
    Bull Cancer; 2003 Feb; 90(2):151-66. PubMed ID: 12660134
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Role of the new version of the Control and Elimination Criteria for Schistosomiasis in acceleration of the schistosomiasis elimination program in China].
    Zhou XN; Xu J; Lin DD; Wang TP; Liang YS; Zhong B; Li SZ; Yang GJ; Jiang QW
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2013 Feb; 25(1):1-4. PubMed ID: 23687801
    [TBL] [Abstract][Full Text] [Related]  

  • 57. NICE guidelines for the diagnosis and treatment of lung cancer.
    Darlison L
    Nurs Times; 2005 Apr 5-11; 101(14):47-8. PubMed ID: 15835336
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Implementation of the German Guideline for the Prevention, Diagnosis, Treatment, and Follow-up of Lung Cancer in the Federal State of Berlin].
    Blum T; Schönfeld N; Goeckenjan G; Jagota A
    Pneumologie; 2013 Feb; 67(2):118-22. PubMed ID: 23250827
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Practice guidelines for non-small cell lung cancer.
    Cameron R; Fringer J; Taylor C; Gilden CR; Figlin RA
    Cancer J Sci Am; 1996; 2(3A Suppl):S61-8. PubMed ID: 9166525
    [No Abstract]   [Full Text] [Related]  

  • 60. [Standardization of diagnosis and treatment is the only way to promote the esophageal cancer treatment and research in China].
    He J
    Zhonghua Zhong Liu Za Zhi; 2012 Apr; 34(4):241-4. PubMed ID: 22781032
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.